Luke N. Robinson
Papers
1
Total Citations
376
H-Index
1
About
Luke N. Robinson is a molecular biologist whose work has fundamentally shaped our understanding of how the liver senses and responds to dietary glucose. His research centers on the molecular mechanisms of metabolic gene regulation, with a particular focus on the transcription factor ChREBP and its role in converting excess carbohydrates into fat. Robinson’s landmark 2006 study, cited over 376 times, established that ChREBP must dimerize with its partner Mlx to function as the principal mediator of glucose-induced gene expression in the liver. This discovery was pivotal: it identified the long-sought molecular switch that couples glucose metabolism to the activation of de novo lipogenesis genes. By demonstrating that the ChREBP•Mlx complex is the primary driver of this pathway, Robinson provided a critical foundation for understanding metabolic diseases like fatty liver disease, obesity, and type 2 diabetes. His work remains essential reading for any researcher exploring nutrient sensing, transcriptional control of metabolism, and the molecular origins of metabolic syndrome.
Research Focus
Key Achievements
Top Papers
- 1